Stockreport

InspireMD targets $13M–$15M in 2026 revenue as CGuard Prime gains U.S. traction [Seeking Alpha]

InspireMD Inc.  (NSPR) 
NASDAQ:AMEX Investor Relations: inspiremd.com/en/investors/investor-relations
PDF Marvin Slosman, President and CEO, emphasized InspireMD's momentum in stroke prevention, stating, "I'm extremely proud of our team here at InspireMD and enthusiastic ab [Read more]